Drug Information| Drug ID:   | NPD4665 |
| Drug Name:   | Nalbuphine |
| Molecular Formula:   | C21H27NO4 |
| Canonical SMILES:   | O[C@H]1CC[C@@]2([C@@]34[C@H]1Oc1c4c(C[C@H]2N(CC3)CC2CCC2)ccc1O)O |
| Standard InCHI:   | "InChI=1S/C21H27NO4/c23-14-5-4-13-10-16-21(25)7-6-15(24)19-20(21,17(13)18(14)26-19)8-9-22(16)11-12-2-1-3-12/h4-5,12,15-16,19,23-25H,1-3,6-11H2/t15-,16+,19-,20-,21+/m0/s1" |
| Standard InCHIKey:   | NETZHAKZCGBWSS-CEDHKZHLSA-N |
| Max Developmental Stage:   | Phase 4 |
| Max Developmental Stage Source:   | TTD; ChEMBL; IUPHAR/BPS |
  Structural Similarity Between NPASS Natural Products and NPD4665Similarity is measured using the Tanimoto coefficient (Tc) , which compares the binary fingerprints of two molecules. Tc is calculated as the intersection divided by the union of '1' bits in the fingerprints, ranging from 0 to 1, with 1 indicating highest similarity.
Tanimoto coefficient is calculated based on PubChem 881-bit substructure fingerprints.
  Similar Natural Products High Similarity: Tc>=0.85; Intermediate Similarity: 0.7 <= Tc < 0.85; Remote Similarity: 0.5 <= Tc < 0.7
| Similarity Level | Similarity Score | Natural Product ID |
|---|---|---|
| Intermediate Similarity | 0.7162 | NPC611959 |
| Remote Similarity | 0.5897 | NPC254045 |
| Remote Similarity | 0.5897 | NPC201055 |
| Remote Similarity | 0.5897 | NPC265000 |
| Remote Similarity | 0.5897 | NPC64576 |
| Remote Similarity | 0.5897 | NPC151470 |
| Remote Similarity | 0.5897 | NPC603205 |
| Remote Similarity | 0.5897 | NPC603486 |
| Remote Similarity | 0.5897 | NPC611632 |
| Remote Similarity | 0.5316 | NPC97086 |
| TTD   | DAP000380; DIB008334; DIB016192 |
| DrugBank   | DB00844 |
| ChEMBL   | CHEMBL895 |
| IUPHAR/BPS   | 1663 |
| PharmaGKB   | PA164745372 |
| KEGG Drug   | D08246 |
| PubChem CID   | 5360733 |
| ChEBI   | 7454 |
| CAS Number   | 20594-83-6 |
| Molecular Weight   | 357.19 |
| ALogP   | -1.6392 |
| MLogP   | 3.22 |
| XLogP   | 0.763 |
| HDA   | 5 |
| HBD   | 3 |
| Rotatable Bonds   | 5 |
| TPSA   | 73.16 |
| RO5 Violation   | 0 |